A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL).

The most frequent chromosomal aberrations in B-cell chronic lymphocytic leukemia (B-CLL) are deletions on 13q, 11q, and 17p, and trisomy 12, all of which are of prognostic significance. Conventional cytogenetic analysis and fluorescence in situ hybridization (FISH) are used for their detection, but cytogenetic analysis is hampered by the low mitotic index of B-CLL cells, and FISH depends on accurate information about candidate regions. We used a set of 400 highly informative microsatellite markers covering all chromosomal arms (allelotyping) and automated polymerase chain reaction (PCR) protocols to screen 46 patients with typical B-CLL for chromosomal aberrations. For validation, we compared data with our conventional karyotype results and fine mapping with conventional single-site PCR. All clonal cytogenetic abnormalities potentially detectable by our microsatellite PCR (eg, del13q14 and trisomy 12) were picked up. Allelotyping revealed additional complex aberrations in patients with both normal and abnormal B-CLL karyotypes. Aberrations detectable in the samples with our microsatellite panel were found on almost all chromosomal arms. We detected new aberrant loci in typical B-CLL, such as allelic losses on 1q, 9q, and 22q in up to 25% of our patients, and allelic imbalances mirroring chromosomal duplications, amplifications, or aneuploidies on 2q, 10p, and 22q in up to 27% of our patients. We conclude that allelotyping with our battery of informative microsatellites is suitable for molecular screening of B-CLL. The technique is well suited for analyses in clinical trials, it provides a comprehensive view of genetic alterations, and it may identify new loci with candidate genes relevant in the molecular biology of B-CLL.

[1]  Y. Pekarsky,et al.  Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene. , 2001, Cancer research.

[2]  I. Bernstein,et al.  Loss of heterozygosity in childhood de novo acute myelogenous leukemia. , 2001, Blood.

[3]  D. Taruscio,et al.  Alteration of chromosome arm 6p is characteristic of primary mediastinal B‐cell lymphoma, as identified by genome‐wide allelotyping , 2001, Genes, chromosomes & cancer.

[4]  H. Döhner,et al.  B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate B-CLL gene on 13q14 comprises more than 560 kb covering all critical regions. , 2001, Human molecular genetics.

[5]  C. Croce,et al.  Cloning and characterization of CLLD6, CLLD7, and CLLD8, novel candidate genes for leukemogenesis at chromosome 13q14, a region commonly deleted in B-cell chronic lymphocytic leukemia. , 2001, Cancer research.

[6]  A. Belenkov,et al.  Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repair. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  W. Liu,et al.  Different mechanisms of radiation-induced loss of heterozygosity in two human lymphoid cell lines from a single donor. , 2001, Cancer research.

[8]  A Benner,et al.  Genomic aberrations and survival in chronic lymphocytic leukemia. , 2000, The New England journal of medicine.

[9]  J. Gutkind,et al.  Loss of PTEN expression leading to high Akt activation in human multiple myelomas. , 2000, Blood.

[10]  P. Lichter,et al.  Comparative genomic hybridization: uses and limitations. , 2000, Seminars in hematology.

[11]  M. L. Le Beau,et al.  Fluorescence in situ hybridization: uses and limitations. , 2000, Seminars in hematology.

[12]  J. Minna,et al.  Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. , 2000, Cancer research.

[13]  C. Yue,et al.  Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis. , 2000, Cancer research.

[14]  K. To,et al.  High resolution allelotype of microdissected primary nasopharyngeal carcinoma. , 2000, Cancer research.

[15]  S. Lam,et al.  High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. , 2000, Cancer research.

[16]  C. Theillet,et al.  17q21-q25 aberrations in breast cancer: combined allelotyping and CGH analysis reveals 5 regions of allelic imbalance among which two correspond to DNA amplification , 1999, Oncogene.

[17]  Peter Lichter,et al.  Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis , 1999, Journal of Molecular Medicine.

[18]  K. Kinzler,et al.  Genetic instabilities in human cancers , 1998, Nature.

[19]  K. Miller,et al.  Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma. , 1998, Cancer research.

[20]  Y. Shiloh,et al.  ATM: from gene to function. , 1998, Human molecular genetics.

[21]  W. Marston Linehan,et al.  Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas , 1998, Nature Genetics.

[22]  Kouji Matsushima,et al.  The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract , 1998, Nature.

[23]  G. Juliusson,et al.  Cytogenetics in chronic lymphocytic leukemia. , 1998, Seminars in oncology.

[24]  Peter Lichter,et al.  Minimal sizes of deletions detected by comparative genomic hybridization , 1998, Genes, chromosomes & cancer.

[25]  M. Raffeld,et al.  PTEN gene alterations in lymphoid neoplasms. , 1998, Blood.

[26]  R. Myers,et al.  Identification and characterization of the human homologue of SH3BP2, an SH3 binding domain protein within a common region of deletion at 4p16.3 involved in bladder cancer. , 1997, Genomics.

[27]  J. Tischfield,et al.  High frequency in vivo loss of heterozygosity is primarily a consequence of mitotic recombination. , 1997, Cancer research.

[28]  R. Gartenhaus.  Allelic loss determination in chronic lymphocytic leukemia by immunomagnetic bead sorting and microsatellite marker analysis , 1997, Oncogene.

[29]  L. Aaltonen,et al.  Microsatellite markers as tools for characterization of DNA amplifications evaluated by comparative genomic hybridization. , 1997, Cancer genetics and cytogenetics.

[30]  M. Fey,et al.  Detection of microsatellite markers in leukaemia using DNA from archival bone marrow smears , 1996, British journal of haematology.

[31]  L. Aaltonen,et al.  Semiautomated assessment of loss of heterozygosity and replication error in tumors. , 1996, Cancer research.

[32]  S. Kern,et al.  Simultaneous assessment of loss of heterozygosity at multiple microsatellite loci using semi-automated fluorescence-based detection: subregional mapping of chromosome 4 in cervical carcinoma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Grever,et al.  National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. , 1996, Blood.

[34]  Cécile Fizames,et al.  A comprehensive genetic map of the human genome based on 5,264 microsatellites , 1996, Nature.

[35]  D. Sidransky,et al.  Mutator phenotype in a subset of chronic lymphocytic leukemia. , 1996, Blood.

[36]  M. Fey,et al.  Frequent clonal loss of heterozygosity but scarcity of microsatellite instability at chromosomal breakpoint cluster regions in adult leukemias. , 1996, Blood.

[37]  F. Mitelman.  ISCN 1995 : an international system for human cytogenetic nomenclature (1995) : recommendations of the International Standing Committee on Human Cytogenetic Nomenclature : Memphis, Tennessee, USA, October 9-13, 1994 , 1995 .

[38]  E. Montserrat,et al.  Chronic lymphocytic leukemia. , 1995, The New England journal of medicine.

[39]  P. Quirke,et al.  Microsatellite instability in colorectal cancer: improved assessment using fluorescent polymerase chain reaction. , 1995, Gastroenterology.

[40]  H. Döhner,et al.  Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses. , 1995, Blood.

[41]  D. Catovsky,et al.  The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. , 1994, Leukemia.

[42]  P. Devilee,et al.  PCR-based microsatellite polymorphisms in the detection of loss of heterozygosity in fresh and archival tumour tissue. , 1993, British Journal of Cancer.

[43]  G. Taylor,et al.  Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. , 1993, British Journal of Cancer.

[44]  A. Philippon,et al.  REFERENCES CONTENT ALERTS Updated information and services can be found at: , 1999 .

[45]  Y. Nakamura,et al.  Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism , 1992, Genes, chromosomes & cancer.

[46]  P. Beris,et al.  Cytogenetic analysis of 54 cases of myelodysplastic syndrome. , 1990, Cancer genetics and cytogenetics.

[47]  E. Eiseman,et al.  Use of phorbol-12,13-dibutyrate as a mitogen in the cytogenetic analysis of tumors with low mitotic indexes. , 1988, Cancer genetics and cytogenetics.

[48]  Stephen E. Fienberg,et al.  Beginning Statistics With Data Analysis , 1984 .

[49]  Chromosomes in Acute Non‐lymphocytic Leukaemia , 1978 .

[50]  Iscn.  International System for Human Cytogenetic Nomenclature , 1978 .